Article

EyeCon 2022: Management options for the treatment of pediatric myopia

Jefferson Doyle, MBBCh, MD, PhD, MHS, of the Wilmer Eye Institute at Johns Hopkins University School of Medicine, addresses myopic concerns, such as public health measures including time outdoors, as well as pharmacological approaches including the current atropine data that has been completed and ongoing studies.

This transcript has been edited for clarity:

My name is Dr. Jefferson Doyle. I'm an assistant professor of ophthalmology and genetics at the Wilmer Eye Institute at Johns Hopkins University.

My talk today is going to cover the current literature discussing management options for the treatment of pediatric myopia. Broadly speaking, this is going to cover public health measures, including time outdoors. It's going to cover pharmacological approaches including the current atropine data that has been completed, and the ongoing studies that are upcoming. We will discuss optical measures. Also orthokeratology is something that's been around for a long time.

More recently, there's been actually contact lens data, looking at dual-focus lenses, as well as most recently, actually, glasses data, again, discussing a dual-focus approach that appears to be very promising.

We'll also discuss the data that actually covers combined approaches, which is somewhat limited at the moment, but there is some out there. Each of these topics will actually we will go over the current challenges that exist, the limitations in where the data is at this moment, and what we hope can be achieved in the future.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.